BRT provides human cell-based and other in vitro assays to evaluate immune function, sensitization, and mechanistic responses across customized preclinical research programs.
BRT offers specialized in vitro approaches to evaluate sensitization, immune function, mechanistic responses, and bioanalytical endpoints across customized preclinical research programs.
In vitro approaches supporting key events in skin sensitization, including regulatory and emerging New Approach Methodologies.
In vitro approaches to evaluate respiratory sensitization, hypersensitivity, and associated immune responses.
Human whole blood, PBMC, and other cell-based assays to evaluate immune function and immunomodulatory responses.
Bioanalytical and cell-based approaches supporting immunogenicity, immune response, and customized assay needs.
BRT has participated as a test site in national and international validation efforts supporting the advancement of in vitro methods for safety assessment.
BRT’s in vitro capabilities can be integrated across immune function, sensitization, and bioanalytical assessments to support customized research programs.
BRT works with clients to develop customized in vitro study designs based on specific research objectives, test articles, assays, and endpoints. In vitro studies can be integrated with in vivo, ex vivo, and bioanalytical assessments to support individual program needs.
